Now Is the Time for Open Access Policies—Here’s Why
March 19, 2020Over the weekend, news emerged that upset even the most ardent skeptics of open access. Under the headline, “Trump vs Berlin” the German newspaper Welt am Sonntag reported that President Trump offered $1 billion USD to the German biopharmaceutical company CureVac to secure their COVID-19 vaccine “only for the United States.” In response, Jens Spahn, the … Read More “Now Is the Time for Open Access Policies—Here’s Why”